Side-by-side comparison of AI visibility scores, market position, and capabilities
Enterprise IT infrastructure with $31.8B FY2024 revenue; $14B Juniper Networks acquisition (pending 2025); GreenLake as-a-service; AI server surge beneficiary with Cray and ProLiant GPU lines.
Hewlett Packard Enterprise (HPE) is a global enterprise IT infrastructure company spun off from Hewlett-Packard in November 2015, headquartered in Spring, Texas and trading on NYSE (HPE). The company reported $31.8 billion in revenues for fiscal year 2024 (ending October 31) under CEO Antonio Neri, spanning servers, storage, networking, and hybrid cloud services. HPE's most significant strategic move of the decade is its pending $14 billion acquisition of Juniper Networks—announced January 2024 and under regulatory review through 2025—which would combine HPE's ProLiant server and Aruba networking portfolios with Juniper's AI-native networking platform, Mist AI, creating a more complete enterprise infrastructure competitor to Cisco.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.